Yahoo Finance • 3 days ago
Horror icon Matthew Lillard is teaming up with Exact Sciences and the Cologuard test to show that screening for colorectal cancer doesn't have to be scary. MADISON, Wis., September 22, 2025--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ:... Full story
Yahoo Finance • 3 days ago
[Wall Street in New York City] JaysonPhotography/iStock via Getty Images With the S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500]) up 13% year-to-date but gains concentrated in a narrow group of large-cap technology names, Jefferie... Full story
Yahoo Finance • 8 days ago
DALLAS, September 17, 2025--(BUSINESS WIRE)--Healthmine, a leading member engagement and rewards platform for health plans, announced a strategic partnership with Exact Sciences, a global leader in cancer diagnostics, to improve colorectal... Full story
Yahoo Finance • 14 days ago
(RTTNews) - Exact Sciences Corp. (EXAS) announced the U.S. launch of Cancerguard™, its multi-cancer early detection or MCED blood test, now available as a laboratory-developed test or LDT. Cancerguard is the first commercial MCED test to... Full story
Yahoo Finance • 20 days ago
Guardant Health stock took a tumble Thursday after the company's second-generation colon cancer test lagged expectations in a pivotal study. Continue Reading View Comments... Full story
Yahoo Finance • 21 days ago
[CAR T cell therapy in Colon, Colorectal cancer (<a href='https://seekingalpha.com/symbol/CRC' title='California Resources Corporation'>CRC</a>) - closeup view 3d illustration] Nemes Laszlo/iStock via Getty Images * Guardant Health (NAS... Full story
Yahoo Finance • 21 days ago
What Happened? Shares of diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) jumped 1.5% in the afternoon session after RBC Capital Markets raised its price target on the company. The investment bank increased its forecast for the... Full story
Yahoo Finance • last month
[3d illustration of colon cancer - colon tumor] peterschreiber.media/iStock via Getty Images * Exact Sciences (NASDAQ:EXAS [https://seekingalpha.com/symbol/EXAS]) has withdrawn its request for a preliminary injunction tied to Geneoscopy... Full story
Yahoo Finance • last month
[Medical industry stock market graph chart] Rasi Bhadramani Hedge funds increased their overweight positioning in health care (NYSEARCA:XLV [https://seekingalpha.com/symbol/XLV]) despite a 7% decline in the sector during the second quarte... Full story
Yahoo Finance • last month
Cathie Wood’s ARK ETF published their daily trades for Thursday, 14th August 2025, revealing a series of significant stock purchases across various sectors. Topping the list in dollar value was the acquisition of 64,789 shares of DEERE & C... Full story
Yahoo Finance • last month
What Happened? A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer Price Index (CPI) report,... Full story
Yahoo Finance • last month
Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of US Personalized Medicine Market size & share revenue was valued at approximately USD 56.37... Full story
Yahoo Finance • last month
Cathie Wood’s ARK ETFs have once again made significant trades on Tuesday, 12 August 2025, with a major focus on tech and biotech stocks. The most substantial trade of the day was the purchase of 738,367 shares of Trade Desk Inc (NASDAQ:... Full story
Yahoo Finance • last month
Key Points Wood added to her positions in The Trade Desk, Pinterest, and Exact Sciences on Friday. The Trade Desk and Pinterest tumbled on Friday after posting disappointing financial results. Exact Sciences has seen its shares slide 13%... Full story
Yahoo Finance • 2 months ago
Exact Sciences Corp. (NYSE:EXAS) on Thursday reported a second-quarter 2025 EPS loss of 1 cent, up from a 9-cent loss a year ago, beating the analyst consensus loss estimate of 19 cents. Revenues increased to $811.085 million, beating the... Full story
Yahoo Finance • 2 months ago
The S&P 500 Index ($SPX) (SPY) today is up +0.48%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.39%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.71%. September E-mini S&P futures (ESU25) are up +0.53%, and September E-mini N... Full story
Yahoo Finance • 2 months ago
Before the opening bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session. [premarket] GAINERS TICKER CHANGE COMMENT IMG [https://www.chartmill.com/stock/... Full story
Yahoo Finance • 2 months ago
The regular session of the US market on Wednesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements. [postmarket] AFTER HOURS GAINERS TICKER CHA... Full story
Yahoo Finance • 2 months ago
Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) will be reporting earnings this Wednesday after market close. Here’s what to expect. Exact Sciences beat analysts’ revenue expectations by 2.7% last quarter, reporting revenues o... Full story
Yahoo Finance • 2 months ago
Cologuard Plus™ Available In-Network August 2025 MADISON, Wis., July 31, 2025--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced an expanded partnership with... Full story